This study further supports the AmpliChip Leukemia Test program, a gene expression microarray test for the subclassification of leukemia.
At present, a microarray test for short pieces of missing or extra chromosomes (chromosomal microarray, CMA) is the recommended test for diagnosing genetic disease in children.
In a validation trial of a DNA microarray test for chlamydiae we repeatedly observed false-positive PCR amplicons from truly negative samples and non-template controls.
A schematic representation of the design and application of the multispecies microarray test to monitor xenobiotic exposure is presented in Figure 2. We assessed male hornyhead turbots sampled at OCSD and LACSD for exposure to xenoestrogens using the multispecies microarray.
Our diagnostic yield of 10% is comparable to, and supplementary to, the diagnostic yield of existing microarray testing for large chromosomal rearrangements and targeted CNV detection.
The DNA microarray test displayed an assay time of 3.5 h, a sensitivity of 100 CFU/ml, and the ability to detect fluoroquinolone-resistant E. coli in the presence of a 10-fold excess of fluoroquinolone-susceptible E. coli cells.
The viruses circulating in Brazil are almost exclusively of genotypes 1, 2 and 3 [16] and the microarray test would fulfill the needs of this large country for HCV genotyping.
*Each column of the data represents the result of one microarray test.
The microarray test with spotted whole antigen of F. tularensis was used for the final evaluation, because pilot experiments showed that spotted LPS lead to many false negative results.
To validate the reliability of the microarray test,6 up-regulated miRNAs (mir-21, mir223, mir224, mir29a, mir29b, and mir27a) and their 4 down-regulated target mRNAs (SFRP1, SFRP2, RNF138, and KLF4) were selected for qRT-PCR examination in 40 matched CRC/normal mucosa tissues whose clinical data were listed in Additional file 1: Table S3.
